Tryg A/S - Annual report 2017

Udgivet den 23-01-2018  |  kl. 06:30  |  

Tryg's Supervisory Board has today approved the annual report 2017. The Supervisory Board find it very satisfactory that all the financial targets for 2017 have been achieved.

Pre-tax 2017 result of DKK 3,239m. Premiums growth of 1.7% in local currency, technical result of DKK 2,789m and investment income of DKK 527m. Proposed quarterly dividend of DKK 1.60 per share bringing the FY dividend to DKK 6.40 per share that supports TryghedsGruppen's 8% member bonus. Extraordinary dividend of DKK 1bn corresponding to DKK 3.31 per share to be approved by the AGM. Solvency ratio of 281 or 196 when adjusted for the capital raised for the acquisition of Alka. As previous communicated, Tryg expects a solvency ratio of approximately 170 when the Alka acquisition is finalised.

Financial highlights 2017 (numbers for 2016 in brackets)  

  • Profit before tax of DKK 3,239m (DKK 3,070m adjusted for one-off)
  • Technical result of DKK 2,789m (DKK 2,640m adjusted for one-off)
  • Combined ratio of 84.4 (85.3 adjusted for one-off)
  • Underlying claims ratio improved in both Private and for the Group
  • Expense ratio of 14.0 (14.8 adjusted for one-off)
  • Premium growth of 1.7% (0.1%) in local currencies
  • Investment return of DKK 527m (DKK 487m adjusted for one-off)
  • Return on equity of 28.8% (26.2%) after tax
  • FY dividend of DKK 6.40 per share and extraordinary dividend of DKK 3.31 per share

Financial highlights Q4 2017 (numbers for 2016 in brackets)

  • Profit before tax of DKK 685m (DKK 650m adjusted for one-off)
  • Technical result of DKK 622m (DKK 564m adjusted for one-off)
  • Combined ratio of 86.0 (87.6 adjusted for one-off)
  • Underlying claims ratio improved in both Private and for the Group
  • Expense ratio of 13.7 (14.4 adjusted for one-off)
  • Premium growth of 1.9% (1.7%) in local currencies
  • Investment return of DKK 86m (DKK 98m adjusted for one-off)
  • Q4 dividend of DKK 1.60 per share

Customer highlights 2017 

  • NPS of 22 (22)
  • Retention rate of 88.1 (88.0)
  • Share of customers with three or more products of 60.7% (57.2%)

Statement by Group CEO Morten Hübbe:

We are pleased to present a technical result, which increases by 6% compared to the 2016 adjusted level and to have met our ambitious 14 expense ratio target which is probably one of the lowest levels in the world compared to similar business models. We continue to see a good premium growth for the Group primarily driven by the Danish Private business. We are also pleased that for the first time in more than ten years, we see a positive customer development for Private and Commercial in all Nordic countries.

Furthermore, we continue to focus on digitalisation and developing new, innovative insurance solutions, which should improve our customers' peace-of-mind, strengthen our core business and create new sources of income. At the same time, we have implemented a number of initiatives to improve customer experience. Amongst other things, we have introduced online meetings, and automated several claims processes.

In December 2017, we announced the biggest transaction of the last twenty years in the Danish non-life market, acquiring Alka. We look forward to welcoming Alka's 365,000 customers and an even broader cooperation with the union.

Finally, it is pleasing that for the second year running, TryghedsGruppen has paid DKK 700m in bonus to approximately 850,000 of our Danish customers and a bonus should be expected for 2018 as well.

Conference call

Tryg hosts a conference call today at 10:00 CET. CEO Morten Hübbe and CFO Christian Baltzer will present the results in brief followed by Q&As.

The conference call will be held in English. An on-demand version will be available shortly after the conference call has ended.
 

Conference call details:

Danish participants:      +45 35 44 55 83

UK participants:            +44 (0) 203 194 0544

US participants:            +1 855 269 2604
 

The annual report material can be downloaded on tryg.com/dk/Investor/Downloads shortly after the time of release.

Vedhæftede filer:

01_2018 Tryg annual report 2017.pdf

Udgivet af: NPinvestordk

Seneste nyheder

17:49 Europa/lukning: Danske fedmeaktier blødte og trak Europa i rødt
17:19 Fredagens obligationer: Renter faldt efter amerikanske inflationstal
17:18 Novo banket i bund efter skuffende data - aktionærerne tabte omkring 690 mia. kr.
17:06 Fredagens aktier: Øretæver til Novo Nordisk og Zealand Pharma giver solid C25-nedtur
15:46 USA/åbning: Eli Lilly vinder på Novos kollaps mens inflationsdata skærer lidt af dykket
15:17 Jeudan har milliarder klar til opkøb: "Øget optimisme kan give flere transaktioner i 2025"
15:15 Novo/Jyske Bank: Kursreaktion virker som overreaktion
14:29 USA/tendens: Eli Lilly vinder på Novos kollaps mens frygt for nedlukning varsler rød start
13:33 Korr: Udsalg af Novo-aktier presser kronen
13:24 Udsalg af Novo-aktier presser kronen
12:29 Sydbank-analytiker: Voldsomt kursfald afspejler skuffelsen over Cagrisema-data
12:25 Europa/aktier: Danske fedmeaktier bløder og trækker Europa i rødt
12:22 Novo smadres på børsen efter skuffende fedmestudie - aktien taber 770 mia. kr.
12:11 Novos styrtdyk trækker C25-indekset ned i sit fjerdestørste fald nogensinde
12:09 Gubra og Zealand Pharma trækkes med ned af negativt nyt til Novo Nordisk
12:05 Novo lever ikke op til egne forventninger i vigtigt studie - aktien mister 900 mia kr -NY2
11:56 Novo lever ikke op til egne forventninger i kursfølsomt studie - aktien mister 700 mia kr
11:48 Aktier/middag: Zealand Pharma bankes tocifret ned efter FDA-afvisning og trækker C25 ned
11:28 Obligationer/middag: Små renteudsving før inflationsnyt fra USA
10:49 Jefferies ser kurslussing til Zealand Pharma som købsmulighed